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Continuous and Intensified Manufacturing of Biologics
Requirements for Intensified & Continuous BioManufacturing
Examples - Implementation of Continuous & Intensified BioManufacturing
• Process development
• Scale-up







BPOG Roadmap - USP Vision Scenario 2 and 3 (SU)
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Continuous and Intensified Manufacturing of Biologics
Fully closed seed train
Robust scalable n-1 perfusion 
Media: Adventitious agent safety
PD: Multi-parallel system for downscaled model processing













Continuous / Intensified Offer: Similar low initial investment + Increased output to mid-large scale
SU Intensified Batch – Best compromise: Speed, COG, Quality, Flexibility 
SU Perfusion/Continuous – Best for product quality, lowest footprint (still several challenges) 
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Standardized Economic Cost Modeling for Next-Generation MAb Production, Pollard et al, BioProcess International 14(8) Sept. 2016 
Continuous and Intensified Manufacturing of Biologics
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Process Requirements  Equipment requirements
(Typical)
Process requirement N-1 perfusion Intensified Batch Perfusion
Run length (days) <8 <21 21 - 90
Cell density (106/mL) <75 50 - 200 50 - 150
Bioreactor size (L) 200 - 500 500 - 2000 500 - 2000
Media flow (VVD) <2 0.5 - 2 1 - 2
Media use (x Wv) <10 5 - 20 20 - 180
Cell bleed No No Yes
Cell bleed (x Wv/day) - - 0.05 – 0.30
Etc.
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Determines equipment design: Witch retention system scale, Ports, Control Recipe  
Requirements for Intensified & Continuous BioManufacturing (USP)
Intensified Batch and Perfusion Bioreactor Set-up
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Cell line select & process development
ambr® 250htambr® 15






CHO DG44 cell lines 
Extreme cell density clarification
Perfusion simulation
ATF/TFF Connectivity, MFCS recipes





RM Perfusion /HCD Cell banking
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Example: Increased throughput ambr® 15 Sedimentation
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ambr® 15 perfusion simulation with sedimentation gives: 
• comparable viable cell densities & product quality to 1L scale, different titers
• Superior media optimization to batch and chemostat
ambr® 15 as a sedimentation-perfusion model for cultivation characteristics and product quality prediction 17.02.2016 Steffen Kreye Glycotope GmbH Berlin
Implementation of Continuous & Intensified BioManufacturing






























































Filter A: Substantial product sieving
Titer in bioreactor
Filter B: No product sieving
Advanced control - Short exponential growth phase: 
Flow rate, rpm, pO2, pCO2, foam, Glucose (optional)
Production phase
Optional biomass control
Sartorius “perfusion packages” for extreme cell density benchtop cultures
• Incl. Vessel configuration, BIOSTAT DCU controller configuration, MFCS advanced control recipes
Implementation of Continuous & Intensified BioManufacturing
+ Spectrum TFF retention system





One-piece bag holder with






System rails for fixing
of accessories
(probe holder, 
exhaust cooler etc. )
Integrated closed temperature loop 
with low pressure TCU 
(p<0,5bar)  no approval 
acc. ASME or PED needed
STR® 50-200: 3kW
STR® 500-1000: 6kWCooling water connection
by heat exchanger (p<6bars)
Piping acc. PED and ASME




TCU-box with separate 
power supply
Filter holder in the 
front, no access from 
the back needed
2nd generation BIOSTAT STR®
Delta V  and other 3rd party 
SCADA connectivity of DCU 
tower similar to B-DCU
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Easier than ever to configure Intensified / Continuous compatible STR Page 11
Example: Scale-up HCD Bioreactor configuration
Gassing out method, PBS, max. working vol., 0,1 vvm, 25°C
STR 200, 2 x 3-blade segment impeller,  
tip speed: 1,8 m/s, gassing-out method, 200 L 1 x PBS
Best oxygen transfer with microsparger & Rushton / marine impeller
Implementation of Continuous & Intensified BioManufacturing
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Example: BIOSTAT STR® 500 reaching 200 mln cells/mL in concentrated 
FB
500 L XD® results comparable to 50L 
 Excellent growth in 500 L system
 VCDs somewhat higher in 500 L system
 Titer similar
Successful scale-up to extreme VCD 
• >200 mln cells/mL in 500 L)
• TFF retention system
• No oxygen or other limitations 
observed
Implementation of Continuous & Intensified BioManufacturing
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Scale-up of extremely high cell density CHO cultures to commercial manufacturing scale in single use bioreactors, Zijlstra, Sartorius Forum 2014
Example: BIOSTAT STR® 2000 Intensified Batch vs. stainless steel
Implementation of Continuous & Intensified BioManufacturing
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Continuous Cell Culture Operation at 2,000-L Scale, Sherman et al., BioProcess International 14(10)s November 2016 
Concentrated Fed-Batch and Perfusion Bleed:  Clarification Challenge
• Cell Culture Broth contains:
• > 100 mln cells/mL  >>30% pellet volume
• > 10 g/L Mab Product 
• Classical clarification technologies are not working at all or not working efficiently:
• Depth filters  Block immediately
• Classical Centrifuges  Substantial product loss with cell slurry 
 HCP release by cell damage
 CIP, SIP dependent
• Solution: kSep® Single Use centrifuge as primary clarification step
Clarification Challenge of Continuous & Intensified BioManufacturing
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Example: Optimized SU Centrifugation for HCD cultures
kSep® for cell harvesting, clarification >100 mln cells/mL without viability loss 
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Clarification Challenge of Continuous & Intensified BioManufacturing
Example: Optimized SU Centrifugation for HCD cultures
kSep product harvest VCD (x 106/mL) Viability (%)
1 Before 59,7 89
After 44,5* 91
2 Before 86,8 92
After 28,8* 88





• Compatible with >100 mln cells/mL cell harvests
• Full product recovery
• No significant viability loss or cell lysis
• Limited product dilution
Clarification Challenge of Continuous & Intensified BioManufacturing
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• Intensified and Continuous BioManufacturing is becoming mainstream. It enables 
Flexible Single Use Facilities for mid- to high volume production scales
• Implementation is not trivial
• More complicated unit operations and controls
• Sartorius has highly suitable solutions for Intensified and Continuous BioManufacturing
• Best in class Process Development Tools (ambr®) for Highly intensified Cell Cultures
• Best in class Single Use Bioreactors (Biostat® STR) for Highly intensified Cell Cultures
• Best in class Single Use centrifuges (kSep®), featuring:
• Compatibility with >100 mln cells/mL cell harvests
• Full product recovery and no significant viability loss or cell lysis at limited product dilution
• PAT solutions for improved process control (e.g. BioPAT® Viamass, Trace)
• Automation with DoE and MVDA integration and support (Umetrics Suite™)
Implementation of Continuous & Intensified BioManufacturing
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